ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,539, issued on Aug. 12, was assigned to Cavion Inc. (Palo Alto, Calif.).
"Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)ethyl)acetamide" was invented by Margaret Scott Lee (Middleton, Mass.), Spyridon Papapetropoulos (Wellesley, Mass.), Michelle S. Higgin (Holly Springs, N.C.), Muralikrishna Duvvuri (Chapel Hill, N.C.), Bruce N. Rehlaender (Cary, N.C.) and Evan Newbold (Charlottesville, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods and materials for treating mammals having, or at risk of developing, one or more movement disorders (e.g., essential tremor, e...